The 14th International Conference on Breast Cancer, Women and Immunotherapy and the Second International Conference on Lung Cancer and Immunotherapy will be launched today, under the auspices of Prof. Dr. Khaled Abdel Ghaffar, Minister of Higher Education and Scientific Research and Acting Minister of Health and Population, Prof. Dr. Mahmoud El Metini, President of Ain Shams University, and Prof. Dr. Ashraf Omar Dean of Faculty of Medicine, with the participation of 12 international societies, including the American Cancer Society (ESCO), the European Society of Gynecological Oncology, the African Society of Oncology (ORTECH), and the European Society of Oncology, to announce the new in oncology and the new global guidelines in oncology and diagnosis.

Dr. Hesham Al-Ghazali, Professor of Oncology at the Faculty of Medicine, Ain Shams University and President of the International Society of Breast, Gynecological Oncology and Immunotherapy, Dr. Yasser Abdel Kader, Professor of Oncology at the Faculty of Medicine, Kasr Al-Ainy, and Dr. Maged Abu Saada, Professor of Gynecology and Gynecological Oncology at the Faculty of Medicine, Ain Shams University, and Dr. Mustafa El-Shazly, Professor of Chest Diseases at Kasr El-Ainy and Director of the French Kasr El-Ainy Hospital for Isolation will participate in the Breast Cancer Conference.

The conference will discuss the use of artificial intelligence in the imaging and pathological diagnosis of breast tumors and women, and the liquid DNA sample for the diagnosis and follow-up of lung tumors.

It is worth noting that during the two conferences, genetic and targeted drugs will be announced for the treatment of breast, lung and ovarian tumors, with the participation of the Ain Shams Medical Research Center to activate vaccines for some types of cancer, localize genetic and informational solutions for oncology patients in Egypt, and announce the use of artificial intelligence in imaging and pathological diagnosis of breast tumors and the use of a DNA sample to diagnose and follow-up lung tumors, in addition to the launch of five new genetic and targeted drugs for the treatment of breast, lung and ovarian tumors, with the participation of the Faculty of Medicine Research Center through research presented to activate vaccines for some types of cancer, and the localization of genetic and informational solutions for tumor patients in Egypt.